Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion type Assertion NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_head.
- NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_provenance.
- NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion evidence source_evidence_literature NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_provenance.
- NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion SIO_000772 20190808 NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_provenance.
- NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion wasDerivedFrom befree-20140225 NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_provenance.
- NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion wasGeneratedBy ECO_0000203 NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_provenance.